NASH and Systemic Complications: From Basic to Clinical Research.
Sabine BaumgartnerRonit Shiri-SverdlovPublished in: Biomedicines (2021)
Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH) [...].